Roblox reported narrower quarterly losses as operational discipline offset softer user engagement metrics, prompting a recalibration among gaming sector investors.

U.S. equities pulled back as a sharp drop in Alphabet shares sparked broader concerns over the timeline and payoff of massive artificial intelligence spending.

Amazon shares retreated after quarterly revenue and guidance fell short of consensus expectations, overshadowing the fastest cloud sales expansion in recent quarters.

Renewed volatility across mega-cap technology shares pushed investors toward government debt, sending benchmark U.S. Treasury yields lower across the curve.

Bristol Myers Squibb is defending its clinical pipeline after a patient death in an autoimmune trial, reassuring investors over its broader immunology strategy.

Alphabet shares are approaching a critical technical milestone as the 50-day moving average threatens to drop below its 200-day counterpart, signaling shifting institutional sentiment.

Under CEO Tony Xu, DoorDash turned suburban expansion and rigorous unit economics into undisputed dominance across the US on-demand delivery sector.

Alphabet ramps up quarterly capital expenditure to historic highs as tech giants pour billions into artificial intelligence compute and hyperscale data centers.

Shell shares rallied strongly after the global energy giant reported a sharp doubling of quarterly earnings, driven by resilient gas trading and disciplined capital allocation.

A selloff swept across major artificial intelligence and semiconductor equities following Alphabet's latest quarterly results, raising investor scrutiny over rising infrastructure expenditures.

Eli Lilly posted significant revenue gains driven by unprecedented global demand for its blockbuster treatments Mounjaro and Zepbound, solidifying its leadership in the metabolic therapeutics market.

Merck posted robust top-line gains driven by enduring demand for blockbuster oncology drug Keytruda and rapid market adoption of newly launched Winrevair.